COVID-19 has rocked markets and caused panic across the world. While investors are feeling the pain as global supply chains may become constricted, playing on COVID-19 stocks has proven very lucrative. Companies are developing a vaccine, testing kit or even household cleaning products have proven not only to be safe havens but also savvy investments. However, there are two sides to every trade.
More and more companies are joining the fight against the new coronavirus, and 24/7 Wall St. is taking a look at some of these companies and their most recent short interest data.
The February 28 short interest data have been compared with the previous figures, and short interest in most of these selected coronavirus stocks increased.
Short interest in Moderna Inc. (NASDAQ: MRNA) increased to 20.15 million shares from the previous 17.13 million. The stock was trading at $24.76 Wednesday morning, within a 52-week range of $11.54 to $36.00.
The number of Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) shares short increased to 2.88 million from 2.65 million in the previous period. Its shares were trading at $469.42, in a 52-week range of $271.37 to $500.00.
Novavax Inc. (NASDAQ: NVAX) saw its short interest decrease to 5.14 million shares from 6.02 million in the prior period. The stock was trading at $10.13. The 52-week range is $3.54 to $17.71.
Gilead Sciences Inc. (NASDAQ: GILD) short interest increased to 23.76 million shares from the previous 21.56 million. Shares traded at $73.73, in a 52-week range of $60.89 to $80.40.
Short interest in NanoViricides Inc. (NYSE: NNVC) increased to 737,500 from the previous 328,200. The stock was trading at $8.33, and its 52-week range is $1.27 to $19.20.
In Lakeland Industries Inc. (NASDAQ: LAKE), short interest increased to 977,800 from the prior 490,000. The stock was trading at $15.72, and the 52-week range is $9.70 to $28.00.
Clorox Co. (NYSE: CLX) short interest rose to 8.94 million shares from the previous 8.70 million. The stock was trading at $171.58. The 52-week range is $144.12 to $178.88.
Co-Diagnostics Inc. (NASDAQ: CODX) short interest rose to 2.46 million shares from the previous 2.18 million. Shares traded at $11.87, in a 52-week range of $0.69 to $21.75.
24/7 Wall St.Credit Card Companies Are Doing Something Nuts
Credit card companies are at war. The biggest issuers are handing out free rewards and benefits to win the best customers.
It’s possible to find cards paying unlimited 1.5%, 2%, and even more today. That’s free money for qualified borrowers, and the type of thing that would be crazy to pass up. Those rewards can add up to thousands of dollars every year in free money, and include other benefits as well.
We’ve assembled some of the best credit cards for users today. Don’t miss these offers because they won’t be this good forever.
Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.